USP <1079> is the governing reference for storage and distribution of finished pharmaceutical products in the United States. It sets the expectations: define your storage conditions, monitor them, demonstrate they're being maintained. It's also a guidance chapter, which means the practical question — "how do I actually conduct a mapping study that will hold up?" — is left to the reader.
Here's what we recommend based on how mapping studies hold up in audits and how they tend to fail.
What 1079 covers (and what it doesn't)
USP <1079> covers good storage and distribution practices for finished pharmaceutical products, including labeling, container integrity, transportation, monitoring, and the qualification of storage environments. It defines storage conditions like Controlled Room Temperature (CRT, 20–25°C with allowable excursions), Refrigerated (2–8°C), and Frozen.
What it doesn't do is prescribe sensor count, study duration, acceptance criteria, or analytical method. Those decisions are yours to make defensibly. The companion chapter <1118> offers more direct guidance on monitoring devices — worth reading alongside 1079.
Sensor density
The most common audit finding on warehouse mapping studies is insufficient sensor density. There's no magic number, but the working principle is that the sensor array has to cover every storage location's environment, including the worst case.
What we recommend:
- Corner positions. All eight corners of the warehouse at storage height (or all four if storage is single-level)
- Center positions. Multiple sensors distributed through the center volume at storage heights, especially in areas with HVAC discharge or return
- Worst-case suspects. Adjacent to dock doors, near HVAC equipment, against exterior walls with sun exposure, near skylights, above heat-generating equipment, near ceiling vs. near floor
- Reference sensor. Co-located with your permanent monitoring sensor so you can correlate the study data with what your monitoring system will see going forward
For a typical pharmaceutical warehouse of 10,000–30,000 square feet at controlled room temperature, that's usually 30–60 sensors. For larger facilities, scale accordingly. Going below 20 sensors anywhere in the audit-defensible range gets challenging.
Study duration
The study has to capture the worst-case temperature exposure the warehouse will see in normal operation. That means:
A January mapping study on a warehouse without a documented summer worst-case is not a complete qualification. Conduct the initial mapping in the season that stresses the HVAC the most — usually summer for cooling-limited warehouses, winter for heating-limited ones — or do two seasonal studies the first year.
Practical duration:
- Minimum 7 days. Captures full weekly operational cycles including weekend HVAC behavior
- Worst-case seasonal. The hottest week of summer, the coldest week of winter, or both
- Door-open testing. Documented dock door open events during the study to capture temperature recovery behavior
- Power interruption (if testable). A planned utility test to characterize how quickly conditions drift if HVAC goes down
Mean kinetic temperature (MKT)
For Controlled Room Temperature storage, the relevant question isn't "did the temperature ever exceed 25°C?" It's "did the time-weighted thermal exposure exceed what the product can tolerate?" Mean kinetic temperature is the calculated answer to that second question.
MKT integrates temperature exposure over time, weighted by the Arrhenius equation, to give a single number that represents the equivalent constant temperature the product effectively experienced. A warehouse that hit 27°C for two hours on a hot afternoon but stayed below 22°C the rest of the week may have an MKT well below 25°C and be entirely acceptable.
Both the study report and the ongoing monitoring program should report MKT. Most modern monitoring systems calculate it automatically. If yours doesn't, that's worth a vendor conversation.
What to do with hotspots
Mapping almost always reveals at least one location that runs warmer than the rest of the warehouse — near a dock door, against a south-facing wall, in a corner with limited HVAC throw. The mapping report has to do something with that finding.
| Hotspot magnitude | Recommended action |
|---|---|
| Within acceptance criteria | Document and continue monitoring. Note in the study report. |
| Above acceptance but transient (recovers within minutes) | Restrict the area to non-temperature-sensitive product, or install supplemental monitoring |
| Above acceptance, sustained | Restrict the area from storage of CRT product. Document the restriction in the warehouse layout. Recheck after any HVAC modification. |
The restriction itself is the corrective action — you don't necessarily need to fix the warehouse. What you can't do is map the hotspot, document it, and then continue to store CRT product there without an action plan. That's the inspection finding that's hardest to walk back.
Key Takeaways
- USP <1079> sets expectations but leaves the specifics — sensor count, duration, acceptance criteria — to your defensible interpretation
- Sensor density should cover corners, center positions, and worst-case suspect areas; for typical pharma warehouses, that's 30–60 sensors
- Conduct the initial study in worst-case season — the January mapping of a sun-exposed warehouse isn't a qualification
- Report mean kinetic temperature, not just min/max — it's the temperature exposure metric that actually matches product impact
- Hotspots either get fixed or get explicitly restricted from CRT storage; mapping them and ignoring them is the audit finding nobody recovers from